Celldex Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $28.9M | $28.4M | $34.8M | $29.4M | $39.1M | $43.8M | $11.2M | $24.3M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $534.7M | $747.2M | $431.7M | $317.7M | $410.8M | $197.8M | $66.7M | $99.1M |
| Property, Plant & Equipment | $5.3M | $4.3M | $4.1M | $3.7M | $3.6M | $3.8M | $4.0M | $6.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $27.2M | $27.2M | $27.2M | $27.2M | $27.2M | $30.7M | $48.7M | $48.7M |
| Total Assets | $583.0M | $792.3M | $465.6M | $352.7M | $444.7M | $235.8M | $122.9M | $155.8M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $3.3M | $3.5M | $3.3M | $1.2M | $1.0M | $1.2M | $1.1M |
| Total Current Liabilities | $51.0M | $39.5M | $31.1M | $18.6M | $16.5M | $14.2M | $11.6M | $12.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $55.8M | $45.3M | $36.5M | $26.5M | $25.2M | $26.5M | $28.9M | $31.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.81B | $-1.56B | $-1.40B | $-1.26B | $-1.14B | $-1.07B | $-1.01B | $-962.4M |
| Total Stockholders' Equity | $527.2M | $747.0M | $429.2M | $326.2M | $419.5M | $209.4M | $94.0M | $124.1M |